Systematic review reveals associations between screening effects on late-stage cancer and mortality outcomes in trials, highlighting important implications.
Figure S1 shows the association between the screening effect on the incidence of late-stage cancer and the screening effect on mortality (trial-level surrogacy), by cancer type where at least three trials were available for analysis.
No takes yet. Share an insight, caveat, or question.
Rebolj et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: